RxDoctor Payments Data

Daniel Santos, MD

Otolaryngology · Owings Mills, MDNPI 1669673075

Payments from drug & device makers

What this record shows

This record is dominated by food and beverage: $2,612 of the $3,420 with a category attached, or 76.4%. 18 manufacturers reported payments, led by Neurent Medical Limited at 28.4% of the total. Reporting peaked in 2024 at $1,223 and has fallen 76.1% since, to $293 in 2025.

$3,420in general payments, 2019–2025

Across 111 payments — averaging $30.81 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Neurent Medical Limited$971
  • Regeneron Healthcare Solutions, Inc.$779
  • GSK$374
  • Optinose US, Inc.$357
  • Sanofi$296
  • Intersect ENT, Inc.$183
  • plus $460 from 12 others

What the payments were for

  • Consulting fees$80824%
  • Food & beverage$2,61276%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$3,420 in reported general payments places this provider in the 75th percentile of 222 otolaryngology providers in Maryland.

See all otolaryngology providers in Maryland

Medicare billing

Part B allowed, 2024
$370,983
Medicare patients
1,270
Services billed
3,300

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Ipratropium Bromide167$4,618
Fluticasone Propionate104$1,582
Budesonide23$1,541
Azelastine Hcl62$1,423
Mometasone Furoate43$898
Ofloxacin34$778
Fluocinolone Acetonide Oil19$578
Amoxicillin-Clavulanate PotassAmoxicillin/Potassium Clav20$202
Mupirocin23$170
Omeprazole25$40

Paid to pharmacies, not to this prescriber.

Other otolaryngology in Owings Mills

See the full list for Maryland

Where these figures come from

Is this you, or does something look wrong? →